Tearsheet

Global Medical REIT (GMRE)

Market Price (12/4/2025): $33.37 | Market Cap: $446.9 Mil
Sector: Real Estate | Industry: Health Care REITs

Global Medical REIT (GMRE)

Market Price (12/4/2025): $33.37
Market Cap: $446.9 Mil
Sector: Real Estate
Industry: Health Care REITs

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 13%, Dividend Yield is 13%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 8.9%	Weak multi-year price returns 2Y Excs Rtn is -70%, 3Y Excs Rtn is -81%	Debt is significant Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 160%
1	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 50%		Expensive valuation multiples P/EPrice/Earnings or Price/(Net Income) is 181x
2	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -26%		Not cash flow generative FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -41%
3	Low stock price volatility Vol 12M is 32%
4	Megatrend and thematic drivers Megatrends include Aging Population & Chronic Disease, and Sustainable & Green Buildings. Themes include Geriatric Care, Oncology Treatments, Show more.

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 13%, Dividend Yield is 13%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 8.9%
1	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 50%
2	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -26%
3	Low stock price volatility Vol 12M is 32%
4	Megatrend and thematic drivers Megatrends include Aging Population & Chronic Disease, and Sustainable & Green Buildings. Themes include Geriatric Care, Oncology Treatments, Show more.
5	Weak multi-year price returns 2Y Excs Rtn is -70%, 3Y Excs Rtn is -81%
6	Debt is significant Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 160%
7	Expensive valuation multiples P/EPrice/Earnings or Price/(Net Income) is 181x
8	Not cash flow generative FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -41%

Valuation, Metrics & Events

	12/4/25	2024	2023	2022	2021
Share Price CYE	$33.37	$35.95	$47.04	$36.77	$63.82
Market Cap CYE ($ Mil)	446.9	480.7	616.8	481.9	821.6
Total Debt ($ Mil)	728.7	657.5	624.2	704.7	579.9
Total Cash ($ Mil)	7.1	6.8	1.3	4.0	7.2
Enterprise Value ($ Mil)	1,168.5	1,138.2	1,241.0	1,186.6	1,401.5
Valuation Ratios
P/S TTM	3.1	3.7	5.2	4.5	9.3
P/EBIT TTM	13.7	14.4	13.8	13.7	28.3
P/E TTM	181.1	76.7	35.3	32.4	61.1
Sector Ratios
P/S TTM (Sector)	0.0	0.0	0.0	0.0	0.0
P/EBIT TTM (Sector)	0.0	0.0	0.0	0.0	0.0
P/E TTM (Sector)	0.0	0.0	0.0	0.0	0.0

	12/4/25	2024	2023
Share Price CYE	$33.37	$35.95	$47.04
Market Cap CYE ($ Mil)	446.9	480.7	616.8
Total Debt ($ Mil)	728.7	657.5	624.2
Total Cash ($ Mil)	7.1	6.8	1.3
Enterprise Value ($ Mil)	1,168.5	1,138.2	1,241.0
Valuation Ratios
P/S TTM	3.1	3.7	5.2
P/EBIT TTM	13.7	14.4	13.8
P/E TTM	181.1	76.7	35.3
Sector Ratios
P/S TTM (Sector)	0.0	0.0	0.0
P/EBIT TTM (Sector)	0.0	0.0	0.0
P/E TTM (Sector)	0.0	0.0	0.0

	GMRE	S&P 500
REVENUE GROWTH	FAIR
Rev LTM ($ Bil)	0.1
Rev Chg Q	8.4%	7.1%
Rev Chg LTM	5.9%	6.1%
Rev Chg 3Y Avg	3.5%	5.5%
PROFITABILITY	POOR
Op Inc LTM ($ Bil)	0.0
CFO LTM ($ Bil)	0.1
Net Inc LTM ($ Bil)	0.0
Op Mgn LTM	23.0%	18.8%
CFO/Rev LTM	50.2%	20.5%
Net Inc Mgn	1.7%	13.1%
VALUATION	MODERATE
P/S	3.1	3.2
P/CFO	6.2	15.8
P/FCF	-7.6	20.5
P/E	181.1	23.5

AI Generated Analysis | Feedback

Metric	Value	Date	Source
Portfolio Leased Occupancy	95.2%	9302025	Link
Buildings Owned	191	11042025	Link
Tenants	315	11042025	Link
Leasable Square Feet	5.2M	11042025	Link
Annualized Base Rent (ABR)	$118.4M	11042025	Link
Weighted Average Lease Term	5.3 years	9302025	Link
Same-Store Cash NOI Growth	2.7%	9302025	Link

Upcoming
2/26/2026	Earnings Release	Rev: - EPS: -

GMRE Stock

Return (1M): 10.68%

null

Why The Stock Moved

Qualitative Assessment

AI Generated Analysis | Feedback

Here are key points that could explain a -9.1% movement in Global Medical REIT (GMRE) stock for the approximate time period from August 31, 2025, to December 4, 2025:

1. Global Medical REIT reported a significant net loss in its Third Quarter 2025 financial results. The company announced on November 4, 2025, a net loss attributable to common stockholders of $6.0 million, or $0.45 per diluted share, for Q3 2025. This contrasts sharply with a net income of $1.8 million, or $0.14 per diluted share, reported in the same period of the prior year, which could negatively impact investor sentiment.

2. An impairment charge on an unoccupied facility contributed to the Q3 2025 net loss. The downturn in Q3 2025 financial results was primarily driven by a $6.3 million impairment charge associated with an unoccupied facility located in Aurora, Illinois. This charge highlights potential asset-specific risks and directly impacted the company's profitability.

3. The announcement and pricing of a public offering of Series B Preferred Stock may have impacted common stock. On November 13, 2025, Global Medical REIT announced and then priced an underwritten public offering of 2,000,000 shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, aiming to raise approximately $50,000,000 in gross proceeds. While intended for general corporate purposes, including new acquisitions and debt repayment, such offerings can sometimes exert downward pressure on common stock prices due to concerns about potential dilution or a perceived need for capital.

4. Analyst sentiment indicated a neutral to bearish outlook for GMRE. As of November 13, 2025, the most recent analyst rating on GMRE stock was a "Hold" with a $33.00 price target. An AI analyst also rated GMRE as "Neutral," citing financial performance challenges, including negative profitability and cash flow issues, and suggested a bearish technical trend.

5. A one-for-five reverse stock split was completed in September 2025. Effective September 19, 2025, Global Medical REIT completed a one-for-five reverse stock split. While a reverse stock split is a technical adjustment designed to increase the per-share price and reduce the number of outstanding shares, it is often perceived by investors as a sign of previous poor performance or underlying financial weakness.

Show less

Stock Movement Drivers

Fundamental Drivers

The -7.4% change in GMRE stock from 9/3/2025 to 12/3/2025 was primarily driven by a -76.2% change in the company's Net Income Margin (%).

	9032025	12032025	Change
Stock Price ($)	35.98	33.31	-7.41%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	141.60	144.46	2.02%
Net Income Margin (%)	7.27%	1.73%	-76.20%
P/E Multiple	46.76	178.59	281.89%
Shares Outstanding (Mil)	13.38	13.39	-0.13%
Cumulative Contribution			-7.41%

LTM = Last Twelve Months as of date shown

Market Drivers

9/3/2025 to 12/3/2025

	Return	Correlation
GMRE	-7.4%
Market (SPY)	6.2%	19.0%
Sector (XLRE)	-1.0%	38.7%

Fundamental Drivers

The 10.6% change in GMRE stock from 6/4/2025 to 12/3/2025 was primarily driven by a 252.2% change in the company's P/E Multiple.

	6042025	12032025	Change
Stock Price ($)	30.12	33.31	10.61%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	137.94	144.46	4.73%
Net Income Margin (%)	5.76%	1.73%	-69.97%
P/E Multiple	50.71	178.59	252.19%
Shares Outstanding (Mil)	13.37	13.39	-0.14%
Cumulative Contribution			10.61%

LTM = Last Twelve Months as of date shown

Market Drivers

6/4/2025 to 12/3/2025

	Return	Correlation
GMRE	10.6%
Market (SPY)	15.1%	23.5%
Sector (XLRE)	-0.8%	43.4%

Fundamental Drivers

The -16.2% change in GMRE stock from 12/3/2024 to 12/3/2025 was primarily driven by a -46.6% change in the company's Net Income Margin (%).

	12032024	12032025	Change
Stock Price ($)	39.77	33.31	-16.23%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	136.39	144.46	5.92%
Net Income Margin (%)	3.24%	1.73%	-46.63%
P/E Multiple	118.31	178.59	50.96%
Shares Outstanding (Mil)	13.15	13.39	-1.87%
Cumulative Contribution			-16.26%

LTM = Last Twelve Months as of date shown

Market Drivers

12/3/2024 to 12/3/2025

	Return	Correlation
GMRE	-16.2%
Market (SPY)	14.3%	38.6%
Sector (XLRE)	-4.3%	57.0%

Fundamental Drivers

The -13.9% change in GMRE stock from 12/4/2022 to 12/3/2025 was primarily driven by a -90.0% change in the company's Net Income Margin (%).

	12042022	12032025	Change
Stock Price ($)	38.69	33.31	-13.91%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	131.19	144.46	10.12%
Net Income Margin (%)	17.21%	1.73%	-89.95%
P/E Multiple	22.46	178.59	695.28%
Shares Outstanding (Mil)	13.10	13.39	-2.21%
Cumulative Contribution			-13.95%

LTM = Last Twelve Months as of date shown

Market Drivers

12/4/2023 to 12/3/2025

	Return	Correlation
GMRE	-23.0%
Market (SPY)	53.2%	38.5%
Sector (XLRE)	14.2%	59.7%

Return vs. Risk

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
GMRE Return	6%	44%	-42%	28%	-24%	-8%	-21%
Peers Return	-17%	10%	-14%	15%	19%	30%	39%
S&P 500 Return	16%	27%	-19%	24%	23%	16%	112%
Monthly Win Rates [3]
GMRE Win Rate	67%	58%	33%	50%	42%	50%
Peers Win Rate	60%	53%	42%	57%	67%	62%
S&P 500 Win Rate	58%	75%	42%	67%	75%	70%
Max Drawdowns [4]
GMRE Max Drawdown	-39%	-4%	-57%	-12%	-26%	-18%
Peers Max Drawdown	-57%	-10%	-26%	-13%	-15%	-6%
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: VTR, HR, SBRA, UHT, WELL.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/3/2025 (YTD)

How Low Can It Go

Unique Key	Event	GMRE	S&P 500
2022 Inflation Shock	2022 Inflation Shock
2022 Inflation Shock% Loss	% Loss	-61.1%	-25.4%
2022 Inflation Shock% Gain to Breakeven	% Gain to Breakeven	156.8%	34.1%
2022 Inflation ShockTime to Breakeven	Time to Breakeven	Not Fully Recovered days	464 days
2020 Covid Pandemic	2020 Covid Pandemic
2020 Covid Pandemic% Loss	% Loss	-49.6%	-33.9%
2020 Covid Pandemic% Gain to Breakeven	% Gain to Breakeven	98.3%	51.3%
2020 Covid PandemicTime to Breakeven	Time to Breakeven	539 days	148 days
2018 Correction	2018 Correction
2018 Correction% Loss	% Loss	-36.5%	-19.8%
2018 Correction% Gain to Breakeven	% Gain to Breakeven	57.4%	24.7%
2018 CorrectionTime to Breakeven	Time to Breakeven	348 days	120 days

Compare to VTR, HR, SBRA, UHT, WELL

In The Past

Global Medical REIT's stock fell -61.1% during the 2022 Inflation Shock from a high on 1/4/2022. A -61.1% loss requires a 156.8% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Global Medical REIT (GMRE)

Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.

AI Generated Analysis | Feedback

Here are 1-3 brief analogies for Global Medical REIT (GMRE):

It's like American Tower, but for hospitals and clinics instead of cell towers.
Think of it as the Prologis of healthcare, owning and leasing medical buildings instead of warehouses.
It's like Simon Property Group, but for medical facilities instead of shopping malls.

AI Generated Analysis | Feedback

Leasing of Healthcare Facilities: GMRE provides long-term leases for its portfolio of medical office buildings, hospitals, and other specialized healthcare properties to healthcare providers.
Healthcare Real Estate Investment: GMRE acquires and manages a diversified portfolio of income-producing healthcare real estate assets across the United States.

AI Generated Analysis | Feedback

Global Medical REIT (GMRE) sells primarily to other companies, specifically healthcare systems, hospital operators, and physician groups, which lease its medical office buildings, hospitals, and other healthcare facilities.

Based on their 2023 Annual Report (10-K), GMRE's major customers (tenants) by percentage of annualized contractual rent as of December 31, 2023, include:

Prime Healthcare Services (Private company)
Prospect Medical Holdings, Inc. (Private company)
Ascension Health (Private, non-profit healthcare system)
Ardent Health Services (Private company)
Quorum Health Corporation (Private company)
Medical Properties Trust (Public company, symbol: MPW)

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

Mark Decker, Jr. Chief Executive Officer and President

Mark Decker, Jr. was appointed as CEO and President of Global Medical REIT, effective June 23, 2025. Prior to joining GMRE, he founded and co-led the net lease real estate investment strategy at Proterra Investment Partners. Before Proterra, Mr. Decker served as President, CEO, Trustee, and Chief Investment Officer at Centerspace (NYSE: CSR) for nearly seven years, where he oversaw the company's transition to a focused apartment owner-operator. His earlier career included over two decades as a senior banker, holding positions such as Managing Director and U.S. Group Head of Real Estate Investment and Corporate Banking at BMO Capital Markets, focusing on growth and transformational transactions for real estate companies.

Robert J. Kiernan. Chief Financial Officer and Treasurer

Robert J. Kiernan joined Global Medical REIT as its Chief Financial Officer in August 2017. He possesses 30 years of experience in financial accounting, reporting, and management. His experience encompasses initial and secondary public offerings, business combinations, SEC filings, and Sarbanes-Oxley compliance. Mr. Kiernan's management and accounting expertise primarily lies within the financial services industry, including broker-dealers, mortgage REITs, and investment funds. Before his tenure at Global Medical REIT, he was Senior Vice President, Controller, and Chief Accounting Officer of FBR & Co. (NASDAQ: FBRC) starting in October 2007, and prior to that, he held the same roles at Arlington Asset Investment Corp. (NYSE: AI) from April 2003. He also served as a Senior Manager in the assurance practice at Ernst & Young.

Alfonzo Leon. Chief Investment Officer

Alfonzo Leon serves as the Chief Investment Officer for Global Medical REIT.

Danica Holley. Chief Operating Officer

Danica Holley is the Chief Operating Officer at Global Medical REIT.

Jamie Barber. General Counsel and Corporate Secretary

Jamie Barber holds the position of General Counsel and Corporate Secretary for Global Medical REIT.

AI Generated Analysis | Feedback

The increasing adoption of telemedicine and virtual care platforms represents a clear emerging threat. As a significant portion of routine medical consultations, diagnoses, and follow-ups shift from physical visits to virtual interactions, the long-term demand for physical medical office buildings, urgent care centers, and other outpatient facilities, which constitute Global Medical REIT's primary assets, could diminish. This trend, accelerated by technological advancements and reinforced by post-pandemic patient and provider preferences, could lead to lower occupancy rates, reduced rental growth, and potential depreciation in asset values for healthcare real estate companies like GMRE.

AI Generated Analysis | Feedback

The addressable markets for Global Medical REIT (GMRE) for their main products or services are in the United States. GMRE primarily focuses on acquiring, financing, and leasing healthcare properties, including medical office buildings (MOBs), inpatient rehabilitation facilities, surgical hospitals, and specialty centers, with MOBs constituting approximately 75% of their portfolio.

The U.S. medical office buildings market was valued at an estimated USD 14,083.8 million in 2023 and is projected to reach USD 22,042.6 million by 2030.
The U.S. hospital facilities market was valued at USD 1,411.7 billion in 2022 and is expected to grow to USD 2,540.4 billion by 2030.
The U.S. ambulatory surgery centers market size was valued at USD 40.41 billion in 2023 and is expected to grow at a compound annual growth rate of 6.02% from 2024 to 2030.
The U.S. ambulatory services market size was estimated at USD 289.5 billion in 2023.
More broadly, the U.S. healthcare real estate market was valued at USD 1.32 trillion in 2024 and is projected to reach USD 1.87 trillion by 2030.

AI Generated Analysis | Feedback

Global Medical REIT (GMRE) is expected to drive future revenue growth over the next two to three years through several key strategies and market dynamics:

Strategic Acquisitions: Global Medical REIT has demonstrated a commitment to expanding its portfolio through strategic acquisitions of medical real estate. In 2024 and 2025, the company completed approximately $150 million in acquisitions with a blended cash yield of 8.5%. More recently, in Q1 2025, GMRE finalized the acquisition of a previously announced five-property medical portfolio for $69.6 million, which is expected to generate an aggregate annualized base rent of $6.3 million. The Chief Investment Officer noted a near-term pipeline of almost $500 million in potential deals, indicating a continued focus on expanding its asset base.
Increased Occupancy Rates: The company aims to improve and maintain high occupancy rates across its portfolio. While the occupancy rate declined to 94.5% in Q2 2025, the successful re-tenanting of a facility in Beaumont, Texas, is expected to contribute to an occupancy rate of over 95% by year-end. As of Q3 2025, the portfolio was 95.2% leased, with expectations for it to trend towards 96% by year-end, which will directly contribute to rental revenue growth.
Contractual Rent Escalations: GMRE's existing lease agreements include weighted average annual rent escalations, which provide a built-in mechanism for revenue growth. As of September 30, 2025, the portfolio had weighted average annual rent escalations of 2.1%. This contractual increase in rental income from existing leases offers a stable component of future revenue growth.
Focus on Outpatient Medical Facilities: The company's strategic focus on outpatient medical facilities aligns with rising demand in the healthcare sector. This positioning is expected to capitalize on market trends and drive revenue growth. GMRE is also considering expanding beyond traditional medical office buildings to further diversify its portfolio and potentially tap into new growth avenues.
New Capital Sources and Joint Ventures: Global Medical REIT is exploring new capital sources, including insurance company debt, to support its investment activities and growth initiatives. Additionally, in March 2025, GMRE formed a strategic joint venture with Heitman LLC, which allows the company to continue investing for both the REIT's balance sheet and through the joint venture, potentially providing additional capital for acquisitions and expansion.

AI Generated Analysis | Feedback

Share Repurchases

In August 2025, Global Medical REIT's Board of Directors approved a common stock repurchase program authorizing the purchase of up to $50 million of its outstanding common shares.
As of November 3, 2025, the company had not repurchased any shares under this program.

Share Issuance

In March 2021, Global Medical REIT completed a follow-on offering of 8,625,000 shares of common stock at $13.30 per share, generating approximately $110.22 million in net proceeds.
In September 2025, the company completed a one-for-five reverse stock split, which reduced its outstanding common shares from approximately 67.0 million to 13.4 million.

Outbound Investments

During 2024 and 2025, the company's acquisition volume totaled approximately $150 million at a blended going-in cash yield of 8.5%.
In Q3 2025, Global Medical REIT completed the acquisition of a five-property medical real estate portfolio for $69.6 million, encompassing 486,598 leasable square feet.
Also in Q3 2025, the company completed five dispositions, generating aggregate gross proceeds of $13.4 million at a 7.0% cap rate.

Capital Expenditures

For the year-to-date in 2025, capital expenditures and leasing commissions amounted to $5.2 million.
The full-year guidance for capital expenditures and leasing commissions for 2025 is projected to be between $12 million and $14 million.

Better Bets than Global Medical REIT (GMRE)

	GMRE	Better Performance than GMRE
Metric	Value	INDUSTRY: Health Care REITs
Rev Chg LTM	5.9%	WELL (32.6%), VTR (15.7%), OHI (13.7%), DOC (9.6%), AHR (9.4%)
Rev Chg 3Y Avg	3.5%	CTRE (21.2%), WELL (20.9%), DOC (11.6%), VTR (10.7%), OHI (6.3%)
Op Mgn LTM	23.0%	OHI (62.4%), CTRE (55.7%), MPW (53.5%), NHI (51.6%), SBRA (35.8%)
CFO/Rev LTM	50.2%	SILA (118.7%), CTRE (107.4%), OHI (76.2%), NHI (63.7%), LTC (56.8%)
FCF/Rev LTM	-41.3%	OHI (76.2%), DOC (44.3%), WELL (28.2%), VTR (17.4%), AHR (8.6%)
Total Yield	13.1%
P/S	3.1	DHC (0.7), STRW (1.1)
P/Op Inc	13.6	STRW (2.1), MPW (6.1)

	GMRE	Better Performance than GMRE
Metric	Value	SECTOR: Real Estate
Rev Chg LTM	5.9%	WELL (32.6%), CBRE (15.0%), O (14.7%), PLD (10.7%), DLR (7.7%)
Rev Chg 3Y Avg	3.5%	WELL (20.9%), PLD (18.1%), DLR (9.1%), EQIX (8.5%), SPG (5.7%)
Op Mgn LTM	23.0%	SPG (50.7%), PSA (47.0%), AMT (46.4%), O (45.7%), PLD (39.8%)
CFO/Rev LTM	50.2%	PSA (67.3%), O (67.1%), SPG (65.3%), VICI (62.0%), PLD (59.3%)
FCF/Rev LTM	-41.3%	PLD (59.3%), SPG (50.7%), AMT (35.3%), WELL (28.2%), EQIX (-1.3%)
Total Yield	13.1%	RYN (24.7%), LXP (22.4%), APLE (14.6%), VNO (13.4%), VICI (13.2%)
P/S	3.1	JLL (0.6), CBRE (1.1), LINE (1.6), HST (2.0), WY (2.5)
P/Op Inc	13.6	VICI (9.5), GLPI (11.5), BXP (11.5), RHP (12.0), SBAC (13.2)

	GMRE	Better Performance than GMRE
Metric	Value	ALL OTHER SECTORS
Rev Chg LTM	5.9%	NVDA (71.6%), MSFT (15.6%), GOOGL (13.4%), AMZN (10.9%), AAPL (6.0%)
Rev Chg 3Y Avg	3.5%	NVDA (92.0%), AVGO (24.0%), MSFT (13.2%), AMZN (11.3%), GOOGL (11.0%)
Op Mgn LTM	23.0%	NVDA (58.1%), MSFT (46.3%), AVGO (39.0%), GOOGL (32.2%), AAPL (31.9%)
CFO/Rev LTM	50.2%	V (57.6%), BAC (57.3%), META (56.8%), MA (56.1%), APP (50.6%)
FCF/Rev LTM	-41.3%	NVDA (43.6%), MSFT (26.6%), AAPL (23.5%), GOOGL (19.1%), AMZN (2.0%)
Total Yield	13.1%	CMCSA (23.8%), VZ (16.8%), TD (16.6%), MO (14.1%), PFE (13.5%)
P/S	3.1	WMT (1.1), XOM (1.4), COST (1.5), HD (2.2), BRK-B (2.7)
P/Op Inc	13.6	VZ (5.9), T (8.3), MRK (9.4), UNH (11.9), XOM (12.4)

		Best Bets In Real Estate Sector
	GMRE
What You Pay
P/E	180.7
P/EBIT	13.6
What You Get
Rev Chg Q	8.4%
Rev Chg LTM	5.9%
Rev Chg 3Y Avg	3.5%
FCF/Rev 3Y Avg	5.7%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 9.6%, alpha of 3.1%, and sharpe of 0.44

Latest Trefis Analyses

	Title	Topic
0	DASHBOARDS
1	Can Global Medical REIT Stock Hold Up When Markets Turn?	Return
2	Global Medical REIT Total Shareholder Return (TSR): -8.8% in 2024 and -3.9% 3-yr compounded annual returns (below peer average)

	Title
0	ARTICLES

Trade Ideas

Select past ideas related to GMRE. For more, see Trefis Trade Ideas.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
MPW_10312025_Short_Squeeze	10312025	MPW	Medical Properties Trust	Special	Short Squeeze PotentialShort Squeeze Potential Has potential for a short squeeze. High short interest, rising short interest and high debt.	8.5%	8.5%	-5.8%

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
MPW_10312025_Short_Squeeze	10312025	MPW	Medical Properties Trust	Special	Short Squeeze PotentialShort Squeeze Potential Has potential for a short squeeze. High short interest, rising short interest and high debt.	8.5%	8.5%	-5.8%

Recent Active Movers

1 Day Top Gainers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
MPLT	MapLight Therapeutics	0.7	31.3%
AEVA	Aeva Technologies	0.8	25.7%	188.2%
DC	Dakota Gold	0.6	19.7%	150.9%
SERV	Serve Robotics	0.7	18.2%	-12.6%
ACDC	ProFrac	0.7	17.6%	-45.0%
HY	Hyster Yale	0.6	15.6%	-29.9%
AEO	American Eagle Outfitters	4.1	15.1%	49.7%
BEAM	Beam Therapeutics	2.7	14.4%	7.8%
GOSS	Gossamer Bio	0.8	14.4%	278.1%
FTRE	Fortrea	1.3	14.4%	-21.8%

1 Day Top Losers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
PSTG	Pure Storage	22.6	-27.3%	12.1%
GTLB	GitLab	6.3	-12.8%	-32.9%
CTEV	Claritev	0.7	-11.3%
FBYD	Falcons Beyond Global	0.7	-11.2%	131.2%
ACHC	Acadia Healthcare	1.3	-10.9%	-63.0%
ULS	UL Solutions	16.0	-10.7%	60.4%
HPK	HighPeak Energy	0.7	-10.6%	-59.8%
OS	OneStream	3.5	-10.4%	-35.0%
ARE	Alexandria Real Estate Equities	8.2	-10.1%	-47.9%
THO	Thor Industries	5.3	-9.5%	6.6%

1 Week Top Gainers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
HPP	Hudson Pacific Properties	6.3	641.5%	-34.3%
TLRY	Tilray Brands	7.5	618.1%	-46.9%
TMC	TMC The Metals	2.8	42.2%	589.3%
VERA	Vera Therapeutics	2.6	40.2%	-2.4%
ARWR	Arrowhead Pharmaceuticals	9.0	39.1%	246.1%
TE	T1 Energy	0.7	37.4%
MPLT	MapLight Therapeutics	0.7	32.1%
AEVA	Aeva Technologies	0.8	31.1%	188.2%
AMKR	Amkor Technology	10.9	30.2%	73.4%
DC	Dakota Gold	0.6	30.2%	150.9%

1 Week Top Losers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
JANX	Janux Therapeutics	1.1	-50.7%	-68.0%
VTYX	Ventyx Biosciences	0.6	-25.0%	258.0%
CTEV	Claritev	0.7	-23.5%
AMBA	Ambarella	3.0	-22.9%	-3.6%
FULC	Fulcrum Therapeutics	0.6	-21.5%	92.8%
PD	PagerDuty	1.1	-20.5%	-33.9%
NTNX	Nutanix	12.7	-19.3%	-22.4%
CNK	Cinemark	2.6	-18.0%	-25.2%
PSTG	Pure Storage	22.6	-17.2%	12.1%
ZS	Zscaler	38.1	-15.9%	35.1%

1 Month Top Gainers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
OLMA	Olema Pharmaceuticals	2.3	223.6%	367.4%
COGT	Cogent Biosciences	5.4	152.6%	402.1%
CDTX	Cidara Therapeutics	5.9	115.1%	722.1%
IRWD	Ironwood Pharmaceuticals	0.6	100.5%	-15.8%
TERN	Terns Pharmaceuticals	2.5	95.9%	396.2%
FRGE	Forge Global	0.6	90.3%	217.8%
SGML	Sigma Lithium	1.1	87.3%	-10.6%
INSP	Inspire Medical Systems	4.0	82.8%	-27.3%
NPCE	NeuroPace	0.6	77.2%	48.9%
ALMS	Alumis	0.6	71.9%	-0.3%

1 Month Top Losers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
UP	Wheels Up Experience	0.4	-52.7%	-62.4%
CCOI	Cogent Communications	0.9	-51.9%	-72.9%
SMR	NuScale Power	3.0	-50.7%	12.3%
FRMI	Fermi	10.3	-47.5%
AMSC	American Superconductor	1.4	-47.2%	30.1%
TLRY	Tilray Brands	7.5	-46.1%	-46.9%
BTDR	Bitdeer Technologies	2.4	-44.8%	-41.8%
EXOD	Exodus Movement	0.4	-43.1%	-53.3%
STUB	Stubhub	3.5	-39.8%
METC	Ramaco Resources	1.0	-39.4%	66.9%

Recent Active Movers

1 Day Top Gainers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
MPLT	MapLight Therapeutics	0.7	31.3%
AEVA	Aeva Technologies	0.8	25.7%	188.2%
DC	Dakota Gold	0.6	19.7%	150.9%
SERV	Serve Robotics	0.7	18.2%	-12.6%
ACDC	ProFrac	0.7	17.6%	-45.0%
HY	Hyster Yale	0.6	15.6%	-29.9%
AEO	American Eagle Outfitters	4.1	15.1%	49.7%
BEAM	Beam Therapeutics	2.7	14.4%	7.8%
GOSS	Gossamer Bio	0.8	14.4%	278.1%
FTRE	Fortrea	1.3	14.4%	-21.8%

1 Day Top Losers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
PSTG	Pure Storage	22.6	-27.3%	12.1%
GTLB	GitLab	6.3	-12.8%	-32.9%
CTEV	Claritev	0.7	-11.3%
FBYD	Falcons Beyond Global	0.7	-11.2%	131.2%
ACHC	Acadia Healthcare	1.3	-10.9%	-63.0%
ULS	UL Solutions	16.0	-10.7%	60.4%
HPK	HighPeak Energy	0.7	-10.6%	-59.8%
OS	OneStream	3.5	-10.4%	-35.0%
ARE	Alexandria Real Estate Equities	8.2	-10.1%	-47.9%
THO	Thor Industries	5.3	-9.5%	6.6%

1 Week Top Gainers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
HPP	Hudson Pacific Properties	6.3	641.5%	-34.3%
TLRY	Tilray Brands	7.5	618.1%	-46.9%
TMC	TMC The Metals	2.8	42.2%	589.3%
VERA	Vera Therapeutics	2.6	40.2%	-2.4%
ARWR	Arrowhead Pharmaceuticals	9.0	39.1%	246.1%
TE	T1 Energy	0.7	37.4%
MPLT	MapLight Therapeutics	0.7	32.1%
AEVA	Aeva Technologies	0.8	31.1%	188.2%
AMKR	Amkor Technology	10.9	30.2%	73.4%
DC	Dakota Gold	0.6	30.2%	150.9%

1 Week Top Losers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
JANX	Janux Therapeutics	1.1	-50.7%	-68.0%
VTYX	Ventyx Biosciences	0.6	-25.0%	258.0%
CTEV	Claritev	0.7	-23.5%
AMBA	Ambarella	3.0	-22.9%	-3.6%
FULC	Fulcrum Therapeutics	0.6	-21.5%	92.8%
PD	PagerDuty	1.1	-20.5%	-33.9%
NTNX	Nutanix	12.7	-19.3%	-22.4%
CNK	Cinemark	2.6	-18.0%	-25.2%
PSTG	Pure Storage	22.6	-17.2%	12.1%
ZS	Zscaler	38.1	-15.9%	35.1%

Peer Comparisons for Global Medical REIT

Peers to compare with:

Financials

	GMRE	VTR	HR	SBRA	UHT	WELL	Median
Name	Global M.	Ventas	Healthca.	Sabra He.	Universa.	Welltower
Mkt Price	33.31	80.00	17.74	19.22	40.61	201.92	36.96
Mkt Cap	0.4	36.5	6.2	4.6	0.6	135.8	5.4
Rev LTM	144	5,555	1,185	745	99	9,752	965
Op Inc LTM	33	818	61	267	36	1,580	164
FCF LTM	-60	968	157	341	49	2,746	249
FCF 3Y Avg	8	687	228	313	46	2,065	270
CFO LTM	72	1,549	463	341	49	2,787	402
CFO 3Y Avg	70	1,297	491	313	46	2,113	402

Growth & Margins

	GMRE	VTR	HR	SBRA	UHT	WELL	Median
Name	Global M.	Ventas	Healthca.	Sabra He.	Universa.	Welltower
Rev Chg LTM	5.9%	15.7%	-6.8%	8.9%	0.7%	32.6%	7.4%
Rev Chg 3Y Avg	3.5%	10.7%	24.9%	7.8%	4.2%	20.9%	9.2%
Rev Chg Q	8.4%	20.4%	-5.6%	6.8%	3.3%	30.7%	7.6%
QoQ Delta Rev Chg LTM	2.0%	4.8%	-1.5%	1.6%	0.8%	6.8%	1.8%
Op Mgn LTM	23.0%	14.7%	5.2%	35.8%	35.8%	16.2%	19.6%
Op Mgn 3Y Avg	25.3%	12.0%	4.6%	35.5%	35.1%	15.1%	20.2%
QoQ Delta Op Mgn LTM	-0.3%	0.0%	1.1%	-1.3%	-0.4%	0.7%	-0.1%
CFO/Rev LTM	50.2%	27.9%	39.1%	45.8%	49.0%	28.6%	42.4%
CFO/Rev 3Y Avg	49.1%	26.3%	38.8%	45.2%	46.9%	26.8%	42.0%
FCF/Rev LTM	-41.3%	17.4%	13.2%	45.8%	49.0%	28.2%	22.8%
FCF/Rev 3Y Avg	5.7%	13.8%	17.8%	45.2%	46.9%	26.1%	22.0%

Valuation

	GMRE	VTR	HR	SBRA	UHT	WELL	Median
Name	Global M.	Ventas	Healthca.	Sabra He.	Universa.	Welltower
Mkt Cap	0.4	36.5	6.2	4.6	0.6	135.8	5.4
P/S	3.1	5.7	5.3	6.0	5.5	12.3	5.6
P/EBIT	13.6	39.9	-40.7	15.5	13.7	79.8	14.6
P/E	180.7	134.1	-17.2	25.5	30.2	124.7	77.5
P/CFO	6.2	20.6	13.6	13.1	11.1	43.0	13.4
Total Yield	13.1%	3.3%	0.7%	10.3%	10.9%	0.8%	6.8%
Dividend Yield	12.5%	2.6%	6.5%	6.4%	7.5%	0.0%	6.5%
FCF Yield 3Y Avg	0.2%	2.8%	3.7%	7.9%	8.0%	2.7%	3.2%
D/E	1.6	0.4	0.7	0.6	0.7	0.2	0.6
Net D/E	1.6	0.4	0.7	0.5	0.7	0.1	0.6

Returns

	GMRE	VTR	HR	SBRA	UHT	WELL	Median
Name	Global M.	Ventas	Healthca.	Sabra He.	Universa.	Welltower
1M Rtn	9.4%	7.9%	2.0%	9.2%	6.3%	11.2%	8.6%
3M Rtn	-7.4%	19.4%	3.1%	2.8%	2.0%	21.1%	2.9%
6M Rtn	10.6%	28.5%	28.1%	12.6%	4.1%	33.9%	20.4%
12M Rtn	-16.2%	31.2%	4.6%	11.5%	7.1%	54.7%	9.3%
3Y Rtn	-13.9%	92.1%	7.7%	87.1%	-7.5%	205.0%	47.4%
1M Excs Rtn	9.4%	8.0%	2.0%	9.2%	6.3%	11.2%	8.6%
3M Excs Rtn	-15.1%	13.6%	-2.6%	-3.0%	-4.4%	15.5%	-2.8%
6M Excs Rtn	-4.1%	13.8%	13.4%	-2.1%	-10.7%	19.2%	5.6%
12M Excs Rtn	-30.9%	15.0%	-10.1%	-3.7%	-10.0%	35.1%	-6.9%
3Y Excs Rtn	-81.3%	28.3%	-59.2%	24.9%	-75.2%	152.5%	-17.2%

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021	2020	2019
Period End	9/30/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Filing Date	11/5/2025	2/28/2025	2/28/2024	3/1/2023	3/1/2022	3/8/2021	3/9/2020
Key Financials
Total Revenue	144	138	141	137	116	94	71
Net Income	2	7	21	19	18	-2	9
EPS	-0.25	0.05	1.15	1.00	0.95	-0.85	0.50
Growth Rates
Total Revenue Growth	5.9%	-1.8%	2.7%	18.4%	23.8%	32.6%	32.7%
Net Income Growth	-43.5%	-67.8%	7.7%	8.6%	1015.4%	-120.8%	-31.5%
Margins
Net Income Margin	1.7%	4.8%	14.6%	14.0%	15.2%	-2.1%	13.1%
Cash & Debt
Total Cash	7	7	1	4	7	6	3
Total Debt	729	658	624	705	580	595	389
Net Debt / (Cash)	722	651	623	701	573	589	387
Cash Flows
Net Cash from Operations	72	70	68	77	69	35	36
Free Cash from Operations	-60	-25	58	-80	-133	-184	-220
Returns to Shareholders
Dividends	57	66	65	64	58	46	35
Share Repurchases	-0	-0	-0	-0	-0	-0	-0

$ Mil \| FY: 12/31	2025Q3	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4
Period End	9/30/2025	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022
Filing Date	11/5/2025	8/6/2025	5/8/2025	2/28/2025	11/7/2024	8/7/2024	5/8/2024	2/28/2024	11/7/2023	8/4/2023	5/5/2023	3/1/2023
Key Financials Quarterly
Total Revenue	37	38	35	35	34	34	35	33	35	36	36	36
Net Income	-5	1	4	3	3	-2	2	1	5	13	2	2
EPS	-0.45	-0.05	0.15	0.10	0.14	-0.25	0.05	-0.05	0.25	0.90	0.05	0.05
Key Financials TTM
Total Revenue TTM	144	142	138	138	136	138	140	141	144	144	142	137
Net Income TTM	2	10	8	7	4	6	21	21	22	27	17	19
Growth Rates Quarterly
Total Revenue Growth	8.4%	10.7%	-1.4%	6.1%	-3.7%	-5.8%	-3.1%	-9.3%	0.4%	7.8%	13.6%	19.7%
Net Income Growth	-240.0%	138.7%	58.2%	359.4%	-29.3%	-112.7%	5.7%	-66.2%	-51.7%	259.7%	-48.3%	-65.3%
Margins Quarterly
Net Income Margin	-12.3%	1.7%	10.3%	8.1%	9.5%	-4.9%	6.4%	1.9%	12.9%	36.6%	5.9%	5.0%
Cash & Debt
Total Cash	7	7	5	7	6	5	1	1	1	2	5	4
Total Debt	729	733	692	658	640	626	630	624	631	639	702	705
Net Debt / (Cash)	722	726	687	651	634	621	629	623	630	637	697	701
Cash Flows Quarterly
FCF from Operations	18	22	12	21	16	19	14	18	17	18	16	18
Cash Flows TTM
FCF from Operations TTM	72	71	68	70	68	68	67	68	69	70	76	77
Returns to Shareholders Quarterly
Dividends	11	15	15	15	15	15	15	15	15	15	15	15
Share Repurchases	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	2.3%	2.2%	2.5%	1.7%	2.4%	2.3%	2.5%	2.3%	2.6%	2.7%	2.6%	2.6%
Return on Invested Capital (ROIC) TTM
ROIC TTM	2.2%	2.1%	2.2%	2.2%	2.4%	2.5%	2.5%	2.6%	2.7%	2.7%	2.6%	2.5%

Segment Financials

Revenue by Segment

$ Mil	2024	2023	2022	2021	2020
Single Segment	141
Other income		0	0	0	0
Rental revenue		137	116	94	71
Total	141	137	116	94	71

Price Behavior

Price Behavior

Market Price	$33.31
Market Cap ($ Bil)	0.4
First Trading Date	06/21/2013
Distance from 52W High	-21.2%
	50 Days	200 Days
DMA Price	$32.07	$34.54
DMA Trend	down	down
Distance from DMA	3.9%	-3.6%
	3M	1YR
Volatility	30.5%	32.3%
Downside Capture	93.52	59.93
Upside Capture	31.42	34.49
Correlation (SPY)	18.9%	38.5%

GMRE Betas & Captures as of 11/30/2025

	1M	2M	3M	6M	1Y	3Y
Beta	0.60	0.22	0.51	0.65	0.63	0.80
Up Beta	0.95	1.32	1.28	1.74	0.69	0.73
Down Beta	1.57	-0.06	-0.32	0.03	0.78	0.77
Up Capture	98%	-1%	28%	51%	22%	44%
Bmk +ve Days	12	25	38	73	141	426
Stock +ve Days	9	17	28	60	116	360
Down Capture	-0%	8%	100%	55%	69%	99%
Bmk -ve Days	7	16	24	52	107	323
Stock -ve Days	10	24	33	63	128	377

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

1Y 5Y 10Y

Based On 1-Year Data

		Comparison of GMRE With Other Asset Classes (Last 1Y)
	GMRE	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	-17.1%	-6.8%	15.3%	58.9%	4.6%	-5.8%	-3.1%
Annualized Volatility	32.1%	17.5%	19.7%	19.4%	15.9%	17.8%	35.7%
Sharpe Ratio	-0.55	-0.55	0.60	2.26	0.09	-0.48	0.04
Correlation With Other Assets		57.0%	38.5%	12.3%	8.2%	60.1%	-0.7%

ETFs used for asset classes: Sector ETF = XLRE, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How

Based On 5-Year Data

		Comparison of GMRE With Other Asset Classes (Last 5Y)
	GMRE	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	-6.8%	5.6%	15.0%	17.9%	11.9%	4.9%	37.1%
Annualized Volatility	28.5%	19.2%	17.1%	15.5%	18.9%	19.0%	49.1%
Sharpe Ratio	-0.22	0.21	0.71	0.93	0.52	0.17	0.64
Correlation With Other Assets		66.0%	48.8%	16.4%	12.5%	69.8%	15.6%

Based On 10-Year Data

		Comparison of GMRE With Other Asset Classes (Last 10Y)
	GMRE	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	3.7%	6.6%	14.5%	14.2%	5.6%	5.4%	76.3%
Annualized Volatility	34.4%	20.6%	18.0%	14.8%	17.7%	20.9%	55.9%
Sharpe Ratio	0.20	0.28	0.69	0.79	0.25	0.23	0.95
Correlation With Other Assets		61.3%	46.5%	10.1%	16.2%	65.1%	12.6%

Short Interest

Short Interest: As Of Date	11142025
Short Interest: Shares Quantity	813,476
Short Interest: % Change Since 10312025	11.4%
Average Daily Volume	180,484
Days-to-Cover Short Interest	4.51
Basic Shares Quantity	13,393,000
Short % of Basic Shares	6.1%

Returns Analyses

	Title
0	Can Global Medical REIT Stock Hold Up When Markets Turn?

SEC Filings

Expand for More

Report Date	Filing Date	Filing
9302025	11052025	10-Q 9/30/2025
6302025	8062025	10-Q 6/30/2025
3312025	5082025	10-Q 3/31/2025
12312024	2282025	10-K 12/31/2024
9302024	11072024	10-Q 9/30/2024
6302024	8072024	10-Q 6/30/2024
3312024	5082024	10-Q 3/31/2024
12312023	2282024	10-K 12/31/2023
9302023	11072023	10-Q 9/30/2023
6302023	8042023	10-Q 6/30/2023
3312023	5052023	10-Q 3/31/2023
12312022	3012023	10-K 12/31/2022
9302022	11042022	10-Q 9/30/2022
6302022	8052022	10-Q 6/30/2022
3312022	5062022	10-Q 3/31/2022
12312021	3012022	10-K 12/31/2021

Insider Activity

Expand for More

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	KIERNAN ROBERT J	CFO and Treasurer	11172025	Buy	31.91	3,000	95,730	95,730	Form
1	Decker Mark Okey Jr	CEO and President	11172025	Buy	32.41	4,093	132,654	1,259,679	Form

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Global Medical REIT (GMRE)

Market Price (12/4/2025): $33.37 | Market Cap: $446.9 MilSector: Real Estate | Industry: Health Care REITs

Global Medical REIT (GMRE)

Market Price (12/4/2025): $33.37Market Cap: $446.9 MilSector: Real EstateIndustry: Health Care REITs

Valuation, Metrics & Events

GMRE Stock

Why The Stock Moved

Qualitative Assessment

Stock Movement Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

About Global Medical REIT (GMRE)

Interactive Breakdown

Better Bets than Global Medical REIT (GMRE)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Global Medical REIT

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Based On 1-Year Data

Based On 5-Year Data

Based On 10-Year Data

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (12/4/2025): $33.37 | Market Cap: $446.9 Mil
Sector: Real Estate | Industry: Health Care REITs

Market Price (12/4/2025): $33.37
Market Cap: $446.9 Mil
Sector: Real Estate
Industry: Health Care REITs